FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155012914> ?p ?o ?g. }

• W2155012914 endingPage "92" @default.
• W2155012914 startingPage "86" @default.
• W2155012914 abstract "Neuroblastoma (NB) is the most common extracranial solid tumor in children. Intensive therapeutic intervention does not prolong the overall disease-free survival rate for this tumor. NB tumor, but not normal tissues, overexpress the disialoganglioside (GD(2)) at the cell surface. Anti-GD(2) whole antibodies (aGD(2)) or their corresponding Fab' fragments were covalently coupled to Stealth immunoliposomes (aGD(2)-SIL or Fab'-SIL), and their binding to GD(2)-positive NB cells was measured. Cytotoxic effects of immunoliposomes loaded with doxorubicin (DXR) were determined. Radiolabelled immunoliposomes were used to evaluate pharmacokinetics (PK). The effectiveness of different liposomal formulations of DXR was tested against a metastatic model of human NB in nude mice. aGD(2)-SIL and Fab'-SIL showed concentration-dependent specific binding and uptake by GD(2)-positive NB cells. DXR entrapped in aGD(2)-SIL or Fab'-SIL (aGD(2)-SIL[DXR], Fab'-SIL[DXR]) showed higher cytotoxicities than nontargeted liposomes (SL[DXR]). DXR-loaded Fab'-SIL (Fab'-SIL[DXR]) also showed specific binding, uptake, and cytotoxic effects on several GD(2)-positive NB cells in vitro. PK studies showed that Fab'-SIL had long-circulating profiles in blood compared with aGD(2)-SIL, with the PK profile for Fab'-SIL being almost identical to that obtained with nontargeted Stealth liposomes. In vivo, long-term survivors were obtained in mice treated with Fab'-SIL[DXR] but not in untreated animals, or those treated with free aGD(2) Fab', Fab'-SIL (no drug), free-DXR, or nontargeted Stealth liposomes[DXR] (no antibody; P < 0.0001). Immunoliposomes containing DXR prevented the establishment and growth of the tumor in all of the organs examined. In conclusion, Fab'-SIL[DXR] formulations led to the total inhibition of metastatic growth of human NB in a nude mouse metastatic model. This formulation should receive clinical evaluation as adjuvant therapy of NB." @default.
• W2155012914 created "2016-06-24" @default.
• W2155012914 creator A5000242295 @default.
• W2155012914 creator A5014632539 @default.
• W2155012914 creator A5014918411 @default.
• W2155012914 creator A5016652732 @default.
• W2155012914 creator A5041501501 @default.
• W2155012914 creator A5053922930 @default.
• W2155012914 creator A5057021485 @default.
• W2155012914 date "2003-01-01" @default.
• W2155012914 modified "2023-10-17" @default.
• W2155012914 title "Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice." @default.
• W2155012914 cites W1498713448 @default.
• W2155012914 cites W1516107827 @default.
• W2155012914 cites W1518207709 @default.
• W2155012914 cites W1536370890 @default.
• W2155012914 cites W1551653638 @default.
• W2155012914 cites W1799336810 @default.
• W2155012914 cites W1825707388 @default.
• W2155012914 cites W1858500974 @default.
• W2155012914 cites W1936567301 @default.
• W2155012914 cites W1951128322 @default.
• W2155012914 cites W1965605868 @default.
• W2155012914 cites W1975298683 @default.
• W2155012914 cites W1977939651 @default.
• W2155012914 cites W1981856846 @default.
• W2155012914 cites W1983671192 @default.
• W2155012914 cites W1992578082 @default.
• W2155012914 cites W1992734626 @default.
• W2155012914 cites W1994684937 @default.
• W2155012914 cites W2003717137 @default.
• W2155012914 cites W2003989093 @default.
• W2155012914 cites W2004013171 @default.
• W2155012914 cites W2005557434 @default.
• W2155012914 cites W2006437878 @default.
• W2155012914 cites W2007897263 @default.
• W2155012914 cites W2010750077 @default.
• W2155012914 cites W2011386610 @default.
• W2155012914 cites W2012046793 @default.
• W2155012914 cites W2014778950 @default.
• W2155012914 cites W2025470299 @default.
• W2155012914 cites W2031630601 @default.
• W2155012914 cites W2034230043 @default.
• W2155012914 cites W2039350685 @default.
• W2155012914 cites W2046075094 @default.
• W2155012914 cites W2065337815 @default.
• W2155012914 cites W2068441417 @default.
• W2155012914 cites W2076941870 @default.
• W2155012914 cites W2087533162 @default.
• W2155012914 cites W2101511312 @default.
• W2155012914 cites W2103036523 @default.
• W2155012914 cites W2109052300 @default.
• W2155012914 cites W2114918609 @default.
• W2155012914 cites W2118878458 @default.
• W2155012914 cites W2137155864 @default.
• W2155012914 cites W2137958593 @default.
• W2155012914 cites W2141612652 @default.
• W2155012914 cites W2141764540 @default.
• W2155012914 cites W2148845753 @default.
• W2155012914 cites W2155118053 @default.
• W2155012914 cites W2158449037 @default.
• W2155012914 cites W2160684474 @default.
• W2155012914 cites W2171617845 @default.
• W2155012914 cites W2409200447 @default.
• W2155012914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12517782" @default.
• W2155012914 hasPublicationYear "2003" @default.
• W2155012914 type Work @default.
• W2155012914 sameAs 2155012914 @default.
• W2155012914 citedByCount "42" @default.
• W2155012914 countsByYear W21550129142012 @default.
• W2155012914 countsByYear W21550129142013 @default.
• W2155012914 countsByYear W21550129142014 @default.
• W2155012914 countsByYear W21550129142015 @default.
• W2155012914 countsByYear W21550129142016 @default.
• W2155012914 countsByYear W21550129142017 @default.
• W2155012914 countsByYear W21550129142018 @default.
• W2155012914 countsByYear W21550129142020 @default.
• W2155012914 countsByYear W21550129142021 @default.
• W2155012914 countsByYear W21550129142022 @default.
• W2155012914 countsByYear W21550129142023 @default.
• W2155012914 crossrefType "journal-article" @default.
• W2155012914 hasAuthorship W2155012914A5000242295 @default.
• W2155012914 hasAuthorship W2155012914A5014632539 @default.
• W2155012914 hasAuthorship W2155012914A5014918411 @default.
• W2155012914 hasAuthorship W2155012914A5016652732 @default.
• W2155012914 hasAuthorship W2155012914A5041501501 @default.
• W2155012914 hasAuthorship W2155012914A5053922930 @default.
• W2155012914 hasAuthorship W2155012914A5057021485 @default.
• W2155012914 hasConcept C109316439 @default.
• W2155012914 hasConcept C112705442 @default.
• W2155012914 hasConcept C126322002 @default.
• W2155012914 hasConcept C150903083 @default.
• W2155012914 hasConcept C153911025 @default.
• W2155012914 hasConcept C154317977 @default.
• W2155012914 hasConcept C159654299 @default.
• W2155012914 hasConcept C185154212 @default.
• W2155012914 hasConcept C185592680 @default.
• W2155012914 hasConcept C202751555 @default.

• next